PL341361A1 - Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant - Google Patents

Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant

Info

Publication number
PL341361A1
PL341361A1 PL98341361A PL34136198A PL341361A1 PL 341361 A1 PL341361 A1 PL 341361A1 PL 98341361 A PL98341361 A PL 98341361A PL 34136198 A PL34136198 A PL 34136198A PL 341361 A1 PL341361 A1 PL 341361A1
Authority
PL
Poland
Prior art keywords
lypophilic
glucocorticosteroid
surfactant
pharmacological compositions
micelles containing
Prior art date
Application number
PL98341361A
Inventor
Gabrielle Sjoequist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PL341361A1 publication Critical patent/PL341361A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL98341361A 1997-12-22 1998-12-22 Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant PL341361A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (en) 1997-12-22 1997-12-22 New formulation
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (1)

Publication Number Publication Date
PL341361A1 true PL341361A1 (en) 2001-04-09

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98341361A PL341361A1 (en) 1997-12-22 1998-12-22 Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant

Country Status (20)

Country Link
EP (1) EP1043973A1 (en)
JP (1) JP2001526210A (en)
KR (1) KR20010024789A (en)
CN (1) CN1283106A (en)
AR (1) AR017220A1 (en)
AU (1) AU1993599A (en)
BR (1) BR9813811A (en)
CA (1) CA2315782A1 (en)
EE (1) EE200000388A (en)
HU (1) HUP0102365A3 (en)
ID (1) ID26945A (en)
IL (1) IL136880A0 (en)
NO (1) NO20003220L (en)
NZ (1) NZ505073A (en)
PL (1) PL341361A1 (en)
SE (1) SE9704833D0 (en)
SK (1) SK9532000A3 (en)
TR (1) TR200001977T2 (en)
WO (1) WO1999032089A1 (en)
ZA (1) ZA9811461B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (en) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (en) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
SE0100901D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JPWO2005018607A1 (en) * 2003-08-20 2007-11-01 味の素株式会社 Pharmaceutical formulations with improved solubility
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (en) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 Precursor micelle preparation and its production process
US20090123390A1 (en) 2007-11-13 2009-05-14 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
ES2729925T3 (en) 2007-11-13 2019-11-07 Meritage Pharma Inc Corticosteroid Compositions
EP2334285A1 (en) * 2008-09-12 2011-06-22 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
CN101982168B (en) * 2010-11-02 2012-05-23 山东大学 Quercetin nano-micelle preparation and preparation method thereof
CN102793678B (en) * 2011-05-26 2017-06-30 邓世明 A kind of preparation method of the Docetaxel injection without tween
DE102011108948A1 (en) * 2011-07-29 2013-01-31 Achim Göpferich Aqueous, colloidal solutions of lipophilic substances, in particular drug solutions
JP5456802B2 (en) * 2012-01-23 2014-04-02 株式会社Ｃａｃ Cell migration promoter and transdermal absorbent for wound treatment
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (en) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR102086316B1 (en) * 2019-09-09 2020-03-09 한국콜마주식회사 Cosmetic composition having excellent percutaneous absorption property

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (en) * 1994-12-22 1998-01-07 Astra Ab PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE MANUFACTURE OF A PROLIPOSOMA POWDER AS USED IN SUCH COMPOSITION, PROCEDURE FOR LAMANUFACTURE OF SUCH COMPOSITION, USE OF SUCH PHARMACEUTICAL COMPOSITION IN THE MANUFACTURE OF A DISPOSAL MEDICINAL PRODUCT.

Also Published As

Publication number Publication date
HUP0102365A2 (en) 2001-11-28
JP2001526210A (en) 2001-12-18
NO20003220L (en) 2000-08-22
ZA9811461B (en) 1999-06-22
WO1999032089A1 (en) 1999-07-01
NZ505073A (en) 2002-09-27
AU1993599A (en) 1999-07-12
EE200000388A (en) 2002-02-15
SE9704833D0 (en) 1997-12-22
BR9813811A (en) 2000-10-03
EP1043973A1 (en) 2000-10-18
CA2315782A1 (en) 1999-07-01
HUP0102365A3 (en) 2002-01-28
CN1283106A (en) 2001-02-07
KR20010024789A (en) 2001-03-26
TR200001977T2 (en) 2000-12-21
IL136880A0 (en) 2001-06-14
ID26945A (en) 2001-02-22
SK9532000A3 (en) 2000-11-07
AR017220A1 (en) 2001-08-22
NO20003220D0 (en) 2000-06-21

Similar Documents

Publication Publication Date Title
PL341361A1 (en) Pharmacological compositions comprising micelles containing a lypophilic glucocorticosteroid and only one surfactant
PL340003A1 (en) Alpha-aryl-n-alkyl nitrones and pharmacological compositions containing them
ZA988452B (en) Solid compositions comprising a cyclosporin and an anionic surfactant
IL136444A0 (en) Cyclosporin-containing microemulsion preconcentrate composition
EP1039946A4 (en) Fibrin mixture and dispenser assembly
EP0730860A3 (en) Mixed micelles
HUP0004912A3 (en) Highly alkaline composition containing a hexyl glycoside as a hydrotrope and its use
AP9901563A0 (en) Compositions containing an a tifungal and a phospholipid
ZA985669B (en) New formulation
GB9704126D0 (en) Surfactants
GB9700803D0 (en) Detergent formulation
EP0998578A4 (en) Sel-10 AND USES THEREOF
EP1018748A4 (en) Oxide superconducting wire material
GB9700234D0 (en) Pallet structure
GB9710933D0 (en) Microemulsion compositions
TW340307U (en) A bib structure
TW333800U (en) Drawn type spoon overlaying assembly structures
AU135382S (en) Combined dispenser and cap
TW365188U (en) Improvement in the structure of a dice
ZA9810885B (en) Cyclosporin-containing microemulsion preconcentrate composition
GB9707099D0 (en) Mixing nozzle
AU131387S (en) Returnable envelope
GB9723868D0 (en) Message dispenser
GB9711645D0 (en) Sun wipes
TW339087U (en) Waste-paper-free pallet (addition 1)